Norfloxacin | Co-trimoxazole | p Value | |
Episodes* | 134 | 67 | |
Hospital acquired SBP | 9 (6.71%) | 7 (10.44%) | NS |
Prophylaxis failure % | 5/130 (3.84%) | 4/64 (6.24%) | NS |
C difficle rate % | 13 (9.7%) | 0 | 0.009 |
30-day mortality % | 25 (18.65%) | 15 (22.38%) | NS |
90-day mortality % | 41 (30.59%) | 16 (23.88%) | NS |
* Excluding patients with community acquired SBP.